Bebida Beverage Company controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile1 entries
2015
FDA action over Koma Unwind labeling and melatonin
The FDA issued a warning letter concerning Koma Unwind’s labeling and the use of melatonin in a beverage. The agency questioned the product’s treatment as a supplement while it was marketed and sold as a drink, and reported sales were halted while corrective action was pursued.